Atrial Flutter in Pediatric Patients

Card Electrophysiol Clin. 2022 Sep;14(3):495-500. doi: 10.1016/j.ccep.2022.05.005. Epub 2022 Aug 25.

Abstract

Atrial flutter (AFL) in pediatric patients is a rare condition as the physical dimensions of the immature heart are inadequate to support the arrhythmia. This low incidence makes it difficult for patients in this particular setting to be studied. AFL accounts for 30% of fetal tachyarrhythmias, 11% to 18% of neonatal tachyarrhythmias, and 8% of supraventricular tachyarrhythmias in children older than 1 year of age. Transesophageal overdrive pacing can be used, instead, with lower success rate (60%-70%). The recommended drugs are digoxin which can decrease the ventricular rate until the spontaneous interruption of the AFL. Digoxin can be combined with flecainide or amiodarone in case of failure.

Keywords: Atrial flutter; Children; Treatment.

Publication types

  • Review

MeSH terms

  • Amiodarone*
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmias, Cardiac / drug therapy
  • Atrial Flutter*
  • Child
  • Child, Preschool
  • Digoxin
  • Flecainide
  • Humans
  • Infant, Newborn
  • Tachycardia

Substances

  • Anti-Arrhythmia Agents
  • Digoxin
  • Flecainide
  • Amiodarone